Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain-Reference-Cited by-同舟云学术

Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain

Published:2022-11-08 Issue:6 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Linertová Renata¹²³⁴^ORCID,Guirado-Fuentes Carmen¹²³⁴^ORCID,Mar-Medina Javier³⁵⁶⁷^ORCID,Teljeur Conor⁸^ORCID

Affiliation:

1. Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Las Palmas de Gran Canaria, Spain

2. Servicio de Evaluación del Servicio Canario de Salud (SESCS), Santa Cruz de Tenerife, Spain

3. Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, Spain

4. Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del Sistema Nacional de Salud (RedETS), Madrid, Spain

5. Basque Health Service (Osakidetza), Debagoiena Integrated Healthcare Organisation, Research Unit, Arrasate-Mondragón, Spain

6. Kronikgune Institute for Health Service Research, Barakaldo, Spain

7. Biodonostia Health Research Institute, Donostia-San Sebastián, Spain

8. Health Information and Quality Authority (HIQA), Dublin, Ireland

Funder

Ministry of Health

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2127983

Reference41 articles.

1. The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States

2. Epidemiology and burden of HPV-related disease

3. Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58

4. European Centre for Disease Prevention and Control. Guidance on HPV vaccination in EU countries : focus on boys, people living with HIV and 9-valent HPV vaccine introduction. [Internet]. Stockholm; 2020. https://www.ecdc.europa.eu/en/publications-data/guidance-hpv-vaccination-eu-focus-boys-people-living-hiv-9vHPV-vaccine.

5. Cost-effectiveness of extending the HPV vaccination to boys: a systematic review

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incremental net benefit of extending human papillomavirus vaccine to boys in oropharyngeal cancer burden: Meta-analysis of cost-effectiveness studies;Journal of Dental Sciences;2024-10

2. Hospitalization burden associated with anus and penis neoplasm in Spain (2016-2020);Human Vaccines & Immunotherapeutics;2024-04

3. Parents' perspectives on dental team as advisors to promote HPV vaccination among Spanish adolescents;Journal of Public Health Dentistry;2024-03-14

4. Trust in Physicians in the Context of HPV Vaccination of Children from the Perspective of Social Exchange Theory: A Representative Study of Polish Parents;Vaccines;2023-10-20

5. Acceptance of HPV vaccination in boys among mothers from selected churches in Accra, Ghana;BMC Public Health;2023-06-01